EUVIMEDEUVIMED entdecken
Crossref

Involvement of Protein Kinase C Delta and Monocarboxylate Transporter 4 in the Development of Statin-Induced Cytotoxicity in a Rhabdomyosarcoma-Derived Cell Line

Keisuke Okamoto, Toya Matsui, Yurika Kikutani, Hinata Ueda, Ayako Furugen, Katsuya Narumi, Masaki Kobayashi

Biological and Pharmaceutical Bulletin · 2026

DOI: 10.1248/bpb.b25-00680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2026. Verfasst von Keisuke Okamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Ni…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Rhabdomyosarcoma, Monocarboxylic Acid Transporters, Muscle Proteins. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins, inhibitors of 3-hydroxy-3-methylglutaryl CoA reductase, are widely prescribed lipid-lowering agents. Nevertheless, their use is occasionally associated with muscle toxicity, including rhabdomyolysis. Exercise reportedly exacerbates statin-induced muscle injury; however, the underlying mechanisms remain poorly understood. Here, we investigated the role of protein kinase C (PKC) signaling in the development of statin-induced cytotoxicity using a rhabdomyosarcoma-derived cell line (RD cells), with particular emphasis placed on the regulation of monocarboxylate transporter 4 (MCT4), a lactate transporter implicated in intracellular acidification and cytotoxic responses. Treatment with simvastatin, atorvastatin, and fluvastatin reduced RD cell viability in a concentration-dependent manner. Co-treatment with bisindolylmaleimide I (BIM), an inhibitor of PKCα, β, γ, δ, and ε, attenuated statin-induced cytotoxicity and tended to suppress simvastatin-induced MCT4 upregulation. Furthermore, co-treatment with Gö6976, a selective inhibitor of PKCα and β, did not mitigate the simvastatin-induced reduction in cell viability. Small interfering RNA-mediated knockdown of PKCδ significantly rescued simvastatin-induced cytotoxicity. Tamoxifen, a clinically available drug with PKC inhibitory activity, including against the δ isoform, attenuated simvastatin-induced cell injury, paralleling the effects of BIM. Collectively, our findings demonstrate that PKCδ contributes to statin-induced cytotoxicity in rhabdomyosarcoma cells, at least in part by regulating MCT4 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsRhabdomyosarcomaMonocarboxylic Acid TransportersMuscle ProteinsProtein Kinase C-deltaHumansCell Line, TumorSimvastatinCell SurvivalFluvastatinIndolesAtorvastatin

Stichwörter der Autor:innen

monocarboxylate transporter 4protein kinase C deltasimvastatinstatintamoxifen

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsMonocarboxylic Acid TransportersSimvastatinMuscle ProteinsSLC16A4 protein, humanProtein Kinase C-deltaFluvastatinIndolesAtorvastatin

Autor:innen und Institutionen

  • Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan.
  • Education Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan.

Zitieren

APA

Okamoto, K., Matsui, T., Kikutani, Y., Ueda, H., Furugen, A., Narumi, K., & Kobayashi, M. (2026). Involvement of Protein Kinase C Delta and Monocarboxylate Transporter 4 in the Development of Statin-Induced Cytotoxicity in a Rhabdomyosarcoma-Derived Cell Line. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00680

Vancouver

Okamoto K, Matsui T, Kikutani Y, Ueda H, Furugen A, Narumi K, et al. Involvement of Protein Kinase C Delta and Monocarboxylate Transporter 4 in the Development of Statin-Induced Cytotoxicity in a Rhabdomyosarcoma-Derived Cell Line. Biological and Pharmaceutical Bulletin. 2026. doi:10.1248/bpb.b25-00680

BibTeX
@article{Okamoto2026,
  author = {Okamoto, Keisuke and Matsui, Toya and Kikutani, Yurika and Ueda, Hinata and Furugen, Ayako and Narumi, Katsuya and Kobayashi, Masaki},
  title = {Involvement of Protein Kinase C Delta and Monocarboxylate Transporter 4 in the Development of Statin-Induced Cytotoxicity in a Rhabdomyosarcoma-Derived Cell Line},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2026},
  doi = {10.1248/bpb.b25-00680}
}
Kostenlos starten →